New antibiotics for
Serious Drug Resistant Infections

Recent Rib-X News

Rib-X Pharmaceuticals, Inc., Appoints Dr. Russel Greig to Board of Directors

Rib-X Pharmaceuticals Announces Presentations at the 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

About Us

Rib-X Pharmaceuticals, Inc. is a product-driven small molecule drug discovery and development company focused on the structure based design of new classes of antibiotics.

Read More…

Pipeline

Delafloxacin

Radezolid

Rχ-02

Rχ-04